| Website | http://pharmacogenetics.ucsf.edu/ |
|---|---|
| Principal Investigator | Kathleen M. Giacomini, PhD |
| Host Institution | University of California, San Francisco |
| Grant Number | GM61390 |
The Pharmacogenetics of Membrane Transporters project (PMT) studies genetic variants of membrane transporters that play a role in drug response pathways. Our proposed studies are focused on two major superfamilies of transporters: SoLute Carrier (SLC) and ATP Binding Cassette (ABC).
To date, PMT has discovered variants in over 40 membrane transporters and functionally characterized over 80 amino acid variants in 11 membrane transporters. These hypothesis generating studies have provided a foundation for studies of genetic variation in drug response.
In our renewal studies, our specific aims are to:
Several genotype to phenotype clinical studies are proposed that link genetic variants identified in our cellular assays to clinical drug response. In addition, our phenotype to genotype studies involve GRAD, the Genetics of Response to Anti-Depressants, a rich resource that has accrued over 1000 individuals and contains information about response and adverse drug response to anti-depressants.
Secretary or Assistant, for contact purposes: